POSTER

Evaluation of the abuse liability of gabapentin and duloxetine in male and female rats using two approaches: intravenous self-administration and conditioned place preference

October 15, 2024

PUBLICATION

A systematic assessment of robustness in CNS safety pharmacology

October 10, 2024

PRESS RELEASES

PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutics for Pain

October 8, 2024

Sleep/Wake and Pharmaco-EEG Capabilities

September 23, 2024

POSTER

Standardized Locomotor and Sensory behavior changes in a graded contusive spinal cord injury model

September 9, 2024

Characterization of Rat Kindling Models

August 29, 2024

PRESS RELEASES

PsychoGenics Inc. Awarded $3 million SBIR Grant to Employ its AI-enabled Platforms to Find Treatments for Rare Disorders

August 28, 2024

Characterization of The APP/PS1 Mouse Model of Alzheimer’s Disease

August 15, 2024

Characterization of The rTg4510 Mouse Model of Alzheimer’s Disease

August 13, 2024